A detailed history of Wallace Advisory Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wallace Advisory Group, LLC holds 9,689 shares of NVO stock, worth $1.27 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
9,689
Previous 9,920 2.33%
Holding current value
$1.27 Million
Previous $902 Million 11.11%
% of portfolio
0.75%
Previous 0.71%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$102.11 - $135.92 $23,587 - $31,397
-231 Reduced 2.33%
9,689 $1 Billion
Q4 2023

Jan 08, 2024

BUY
$87.78 - $105.45 $340,235 - $408,724
3,876 Added 64.13%
9,920 $902 Million
Q3 2023

Oct 05, 2023

SELL
$90.94 - $199.54 $4,728 - $10,376
-52 Reduced 0.85%
6,044 $978 Million
Q1 2023

May 10, 2023

SELL
$132.34 - $159.14 $39,569 - $47,582
-299 Reduced 4.68%
6,096 $970 Million
Q4 2022

Feb 21, 2023

BUY
$102.55 - $135.33 $655,807 - $865,435
6,395 New
6,395 $865 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $297B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wallace Advisory Group, LLC Portfolio

Follow Wallace Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wallace Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wallace Advisory Group, LLC with notifications on news.